A61K41/17

Method for preparing live attenuated vaccine by irradiation and live attenuated vaccine composition prepared by the same

The present invention relates to a method of preparing a live attenuated vaccine by irradiation and a live attenuated vaccine composition prepared by the same, and more particularly, a method of preparing a live attenuated vaccine by irradiation including irradiating a pathogenic microorganism with a dose of 0.5 to 2 kGy of radiation per single radiation six to fifteen times; and a live attenuated vaccine composition including a pathogenic microorganism attenuated to not be revertant to a wild type by generation of at least one mutation of nucleotide insertion and nucleotide deletion by irradiation.

APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN TREATING INFECTION ASSOCIATED WITH BURN OR SCALD INJURY
20220370588 · 2022-11-24 · ·

The present invention belongs to the field of microbiology, and particularly relates to an application of a Pseudomonas aeruginosa vaccine in prevention and treatment of burn and scald complicated with bacterial infection. The burn and scald of the present invention include burns and scalds, and degree of the scalds includes I degree, superficial II degree, deep II degree, or III degree scalds. Site of the scalds includes skin, mucosa or other tissues. The Pseudomonas aeruginosa vaccine of the present invention can effectively prevent and treat burn and scald complicated with Pseudomonas aeruginosa infection caused by multidrug-resistant Pseudomonas aeruginosa by activating the specific immune response of the body. The Pseudomonas aeruginosa vaccine of the present invention can reduce the bacterial load in the immunized subject through the established immunization procedures, thereby providing a technical solution that can effectively prevent burn and scald complicated with Pseudomonas aeruginosa infection, which avoids the technical problems caused by the use of antibiotics such as poor effectiveness, difficulty in curing and proneness to drug resistance in the prior art to a certain degree.

METHODS OF PREVENTING PLATELET ALLOIMMUNIZATION AND ALLOIMMUNE PLATELET REFRACTORINESS AND INDUCTION OF TOLERANCE IN TRANSFUSED RECIPIENTS
20230097946 · 2023-03-30 · ·

Methods and compositions for the prevention or reduction of platelet transfusion associated complications are provided. The subject methods include modifying donor whole blood or platelets prior to transfusion to prevent or reduce alloimmune platelet refractoriness.

METHODS OF PREVENTING PLATELET ALLOIMMUNIZATION AND ALLOIMMUNE PLATELET REFRACTORINESS AND INDUCTION OF TOLERANCE IN TRANSFUSED RECIPIENTS
20230097946 · 2023-03-30 · ·

Methods and compositions for the prevention or reduction of platelet transfusion associated complications are provided. The subject methods include modifying donor whole blood or platelets prior to transfusion to prevent or reduce alloimmune platelet refractoriness.

PEPTIDE PARTICLES AND METHODS OF FORMATION

The present disclosure relates to compositions and methods that enable the formation of pharmaceutically relevant particles that can be used for therapy. In particular, the methods disclosed herein allow the controlled formation of circular particles comprising biologically active peptides.

PEPTIDE PARTICLES AND METHODS OF FORMATION

The present disclosure relates to compositions and methods that enable the formation of pharmaceutically relevant particles that can be used for therapy. In particular, the methods disclosed herein allow the controlled formation of circular particles comprising biologically active peptides.

MANUFACTURING OF SELENIUM DISULFIDE COMPOSITIONS

Described herein are methods for the manufacture of compositions useful for the treatment of meibomian gland dysfunction. Said methods utilize rheological properties of petrolatum induced by a high shear mixing feature of the method. The products of the methods of manufacture described herein are stable anhydrous composition of selenium disulfide which are substantially free of selenium disulfide agglomerates and degradation products.

MANUFACTURING OF SELENIUM DISULFIDE COMPOSITIONS

Described herein are methods for the manufacture of compositions useful for the treatment of meibomian gland dysfunction. Said methods utilize rheological properties of petrolatum induced by a high shear mixing feature of the method. The products of the methods of manufacture described herein are stable anhydrous composition of selenium disulfide which are substantially free of selenium disulfide agglomerates and degradation products.

METHOD FOR PRODUCING RADICALS, METHOD FOR STERILIZING SPORES, AND CANCER TREATMENT DRUG
20220339596 · 2022-10-27 ·

Provided is a novel method that makes it possible to easily sterilize spores and the like in a highly safe manner. A method for producing radicals according to the present invention includes a generation step of generating radicals through photoirradiation of a radical generation source, and the peak wavelength of light used in the photoirradiation is greater than UV wavelengths and 600 nm or less. Also, a method for sterilizing spores according to the present invention includes a treatment step of generating radicals through photoirradiation of a radical generation source and treating spores with the radicals, and the peak wavelength of light used in the photoirradiation is greater than UV wavelengths and 600 nm or less. The peak wavelength is, for example, 405 to 470 nm.

METHOD FOR PRODUCING RADICALS, METHOD FOR STERILIZING SPORES, AND CANCER TREATMENT DRUG
20220339596 · 2022-10-27 ·

Provided is a novel method that makes it possible to easily sterilize spores and the like in a highly safe manner. A method for producing radicals according to the present invention includes a generation step of generating radicals through photoirradiation of a radical generation source, and the peak wavelength of light used in the photoirradiation is greater than UV wavelengths and 600 nm or less. Also, a method for sterilizing spores according to the present invention includes a treatment step of generating radicals through photoirradiation of a radical generation source and treating spores with the radicals, and the peak wavelength of light used in the photoirradiation is greater than UV wavelengths and 600 nm or less. The peak wavelength is, for example, 405 to 470 nm.